PharmaBiome is a revolutionary brand at the forefront of the microbiome field. With a deep understanding of the function and complexity of the microbiome, they develop innovative solutions for targeted treatment of microbiome-linked conditions. Their groundbreaking products are designed to reduce microbiome complexity into defined and scalable microbiome ecosystems, ensuring the desired therapeutic activity.

Driven by a passion for novel solutions, PharmaBiome's team of experts develops bacterial consortia tailored to specific diseases. By leveraging their profound insights into the functional networks of bacteria, they are able to create and co-culture bacterial mixes rapidly. The results from pre-clinical models for inflammatory and cancerous diseases have been highly promising, inspiring them to advance rapidly towards clinical trials.

PharmaBiome is committed to making a difference in the microbiome revolution. Contact them today to learn more about their cutting-edge therapies and contribute to their groundbreaking research